For complex medical device systems, teams must define what must happen across subsystem boundaries, assign responsibility for ...

On Sept. 16, 2026, the International Organization for Standardization (ISO) published the sixth edition of ISO 9001. Most medical device professionals shrugged. We live in ISO 13485. We answer to the ...

PFAS exposure for device manufacturers no longer hinges on a single rule or a single material. FDA has drawn a firmer line around fluoropolymers, yet state reporting requirements, a still-evolving EU ...

For the better part of a decade, the default advice handed to medtech founders planning a first-in-human (FIH) study fit in three words: go to Australia. The pitch was seductive and, for a while, ...

Enrolling a large number of healthy travelers into a fixed-budget study without sites puts two pressures on the operation: the volume of lead handoffs and the interest that fades while a pre-qualified ...

A clean GLP audit or a smooth pre-IND interaction feels like proof of control, yet companies that pass inspections still hit submission delays and longer diligence cycles as programs advance. The ...

Familiarity can make manual quality systems look sturdier than they are. Spreadsheets, shared drives, and siloed eQMS platforms may feel dependable until an inspector starts tracing a document history ...

Quality systems run on spreadsheets, paper, and aging legacy tools cost more than most GxP organizations account for. This brochure makes the business case for electronic quality management, pairing ...

AI-assisted drafting of CAPAs, deviation write-ups, and regulatory correspondence is probably already happening on your quality team, with no policy and no record. This paper argues the exposure is ...

A clean audit does not necessarily mean a medical device company is prepared for its next submission, product launch, or acquisition. Teams may pass audits consistently while still reconstructing ...

Drug delivery supply chains can become complicated quickly. Every handoff adds time, cost, communication risk, quality risk, and accountability gaps. Medbio’s model is built to reduce that complexity.

Most quality leaders recognize the symptoms: audit prep that takes weeks, CAPAs that run past due, training records that are slow to retrieve. The harder question is where the system actually sits on ...